Discussing Astorg's plans for scaling Thermo Fisher’s microbiology business, which it agreed to buy for over $1 billion; lots ...
The private equity group plans to accelerate growth of the acquired business, including by empowering it to engage in M&A.
Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about ...
The unit generated $645 million in revenue in 2025 and supplies products used in clinical, pharmaceutical, and food safety ...
OPEN Health is one of the leading global providers of scientific communications and market access services helping pharmaceutical companies to unlock the full potential of their clinical and ...
Thermo Fisher Scientific is shedding its microbiology business to private equity firm Astorg nearly a year after initial ...
Thermo Fisher Scientific said on Monday it has agreed to sell its microbiology business to a pan-European private ...
A consortium jointly led by Astorg and Cinven has announced that it has signed an agreement to acquire LGC, a company in the life sciences tools sector. LGC provides a comprehensive range of ...
According to GlobalData analyst Dr Andrew S Thompson, the deal signals Thermo Fisher’s move away from the IVD space.
The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results